Results from study with Episealer® Knee implant accepted for presentation at Swedish orthopaedic congress
Episurf Medical (Nasdaq: EPIS B) today announces that the abstract “Clinical results after treatment with a patient customised mini metal implant for focal cartilage damage in the knee”, has been accepted for a podium presentation at the Swedish Orthopaedic Society's annual congress, which will take place in Malmö, Sweden, on August 29 – September 2, 2022. The presentation will be held by Prof. Karl Eriksson from Stockholm South Hospital and The Karolinska Institute, Stockholm, Sweden. The abstract reports on the clinical outcome for patients having undergone treatment with Episurf